These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 9923557

  • 21. Docetaxel as second-line chemotherapy for advanced non-small cell lung cancer.
    Thongprasert S, Cheewakriangkrai R, Napapan S.
    J Med Assoc Thai; 2002 Dec; 85(12):1296-300. PubMed ID: 12678167
    [Abstract] [Full Text] [Related]

  • 22. Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic or unresectable localized non-small-cell lung cancer.
    Kim YH, Kim JS, Choi YH, In KH, Park HS, Hong DS, Jeong TJ, Lee YY, Nam E, Lee SN, Lee KS, Kim HK.
    Int J Clin Oncol; 2002 Apr; 7(2):114-9. PubMed ID: 12018108
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R, Hornedo J, Colomer R, Mendiola C, Brandariz A, Sevilla E, Alvarez-Vicent J, Cortés-Funes H.
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature.
    Gridelli C, Frontini L, Barletta E, Rossi A, Barzelloni ML, Scognamiglio F, Guida C, Gatani T, Fiore F, De Bellis M, Marfella A, Manzione L.
    Anticancer Res; 2000 Dec; 20(2B):1077-84. PubMed ID: 10810400
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial.
    Mavroudis D, Kourousis C, Androulakis N, Kalbakis K, Agelaki S, Kakolyris S, Souglakos J, Sarra E, Vardakis N, Hatzidaki D, Sarmonis G, Georgoulias V.
    Am J Clin Oncol; 2000 Aug; 23(4):341-4. PubMed ID: 10955859
    [Abstract] [Full Text] [Related]

  • 31. Combination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: a multicenter phase II study of the Greek Cooperative Group for Lung Cancer.
    Georgoulias V, Androulakis N, Bouros D, Kouroussis C, Chatzakis K, Papadakis M, Apostopoloulou F, Georgopoulou T, Kotsakis T, Souklakos J, Hatzidaki D, Vlachonikolis J, Panagos G.
    Lung Cancer; 1998 Sep; 21(3):213-20. PubMed ID: 9857999
    [Abstract] [Full Text] [Related]

  • 32. Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.
    Fossella FV, Lee JS, Shin DM, Calayag M, Huber M, Perez-Soler R, Murphy WK, Lippman S, Benner S, Glisson B.
    J Clin Oncol; 1995 Mar; 13(3):645-51. PubMed ID: 7884425
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer.
    Mattson K, Vansteenkiste J, Stupp R, Bargetzi M, Saarinen A, Jekunen A, Fillet G, Teixeira M, Gatzemeier U, Olivares R, Soussan-Lazard K, Bérille J.
    Anticancer Drugs; 2000 Jan; 11(1):7-13. PubMed ID: 10757557
    [Abstract] [Full Text] [Related]

  • 36. Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel.
    Chen YM, Shih JF, Lee CS, Chen MC, Lin WC, Tsai CM, Perng RP.
    Lung Cancer; 2003 Feb; 39(2):209-14. PubMed ID: 12581575
    [Abstract] [Full Text] [Related]

  • 37. Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancer.
    Fujita A, Takabatake H, Tagaki S, Sekine K.
    Cancer Chemother Pharmacol; 2000 Feb; 45(4):279-83. PubMed ID: 10755315
    [Abstract] [Full Text] [Related]

  • 38. Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trial.
    Gandara DR, Vokes E, Green M, Bonomi P, Devore R, Comis R, Carbone D, Karp D, Belani C.
    J Clin Oncol; 2000 Jan; 18(1):131-5. PubMed ID: 10623703
    [Abstract] [Full Text] [Related]

  • 39. Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin.
    Kakolyris S, Kouroussis C, Kalbakis K, Mavroudis D, Souglakos J, Nvardakis, Kremos S, Georgoulias V.
    Ann Oncol; 2000 Jun; 11(6):757-60. PubMed ID: 10942068
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.